2017 united states phenylketonuria (pku) market overview

2017 United States Phenylketonuria (PKU) Market Overview Email: sale@qyresearch.com Tel:0086-20-86655165 http://www.qyresearch.com

2017 United States Phenylketonuria (PKU) Market Overview

1

Author: Zhang Chunjiao Publisher: QYResearch

Published Date: May 2017

Recently, QYResearch published a report on United States phenylketonuria (PKU) market.

Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral

problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to

mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.

In the last several years, United States market of Phenylketonuria (PKU) developed rapidly, with an

average growth rate of 11%. In 2016, global revenue of Phenylketonuria (PKU) is nearly 438 M USD.

The classification of Phenylketonuria (PKU) includes medications, supplements and others, and the

proportion of supplements in 2016 is about 29 and the revenue proportion of medications is about 57%.

Phenylketonuria (PKU) is widely used in household, hospital and other field. The most proportion of Phenylketonuria (PKU) is in household, and the sales proportion in 2016 is about 60%.

South Atlantic is the largest consumption place, with a consumption market share nearly 24% in 2016.

Following South Atlantic, Pacific is the second largest consumption place with the consumption market share of 23%.

2017 United States Phenylketonuria (PKU) Market Overview

2

Market competition is intense. Biomarin, Vitaflo, Mead Johnson, Nutricia, etc. are the leaders of the

industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

This article was first released by QYResearch analyst, if reproduced, please indicate the source.

Media Contact: press@qyresearch.com

Analyst : zhangchunjiao@qyresearch.com

2017 United States Phenylketonuria (PKU) Market Overview

3